//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
8,589.80308.7
Stock Analysis, IPO, Mutual Funds, Bonds & More

Lupin Ltd.

ET 500

Rank 2019
95
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    12:24 | 31-03-2020
  • BSE
    12:34 | 31-03-2020
581.00

Today's Change

20.40 (3.64%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

1,864,414

Open

573.00

Prev. Close

560.60

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)2.00
  • EPS-TTM (Rs.)-8.16
  • BV/share (₹)304.74
  • 52Wk L/H544.25/ 914.90
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News

Lupin Ltd Stock Price F & O Quotes

Buy Lupin, price target Rs 580: Shrikant Chouhan| Recos
Buy
Buy Lupin, price target Rs 805: Kunal Bothra| Recos
Buy
Buy Lupin, price target Rs 785: Shrikant Chouhan| Recos
Buy
Buy Lupin, target Rs 777: Kunal Bothra| Recos
Buy
Buy Lupin, target Rs 782: Kunal Bothra| Recos
Buy
Buy Lupin, price target Rs 835: Jay Thakkar| Recos
Buy
Buy Lupin, price target Rs 840: Chandan Taparia| Recos
Buy
Buy Lupin, price target Rs 850: Shrikant Chouhan| Recos
Buy
Buy Lupin, price target Rs 840: Kunal Bothra| Recos
Buy
Buy Lupin, price target Rs 805: Jayesh Bhanushali| Recos
Buy
Buy Lupin, target Rs 805: Kunal Bothra| Recos
Buy
Equirus retains reduce on Lupin, target price Rs 684| Recos
Reduce
Hold Lupin, target Rs 861: Karvy Stock Broking| Recos
Hold
Sell Lupin, target Rs 800: Elara Capital| Recos
Sell
Reduce Lupin, target Rs 840: Kotak Institutional Equities| Recos
Reduce
Buy Lupin, target Rs 820: Dr CK Narayan| Recos
Buy
Buy Lupin, target Rs 820: Kunal Bothra| Recos
Buy
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Earnings Call Transcript| Announcement
Inventory buffer to keep pharma healthy for now| News
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Investor Presentation| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Lupin Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement

Lupin Ltd. Share Price Updates

Lupin Ltd. share price up by 3.64% from its previous close of Rs 560.60. Lupin Ltd. stock last traded price is 581.00
Lupin Ltd. Share Price
Value
Today/Current/Last
581.00
Previous Day
560.60
What's your view on Lupin for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Lupin Ltd.

Lupin Ltd.
Quarterly Results

Figures in Rs. Cr
Dec 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
3,716.09
-13.52
-15.12
0.00
8154.85
Other Operating Income
53.18
-15.25
-58.10
0.00
136.45
Operating Profit
429.10
-41.30
-42.98
-27.67
2683.77
Other Income
93.59
-29.77
115.55
-0.05
119.88
EBITDA
522.69
-39.53
-34.33
-27.67
2683.77
Interest
88.60
2.48
11.07
-0.10
111.00
Depreciation
253.23
-21.23
-9.48
0.00
546.99
Tax
767.02
2136.21
209.53
-9.24
767.02
Net Profit
-835.00
557.12
450.25
-835.00
1019.38
EPS (₹)
-18.45
556.58
449.11
-94.30
31.95

Lupin Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
583.40
4.07
-1.49
-8.84
-23.58
-21.12
-59.63
-70.95
433.60
0.43
14.88
7.83
-9.33
-18.02
-26.87
-39.14
403.95
3.71
23.85
-20.09
-11.58
-48.49
-40.17
-33.87
259.00
2.72
-6.99
-0.40
1.85
-25.37
-41.40
-25.65
2314.65
-0.92
4.44
-11.84
14.93
32.20
4.98
0.00
1377.05
5.39
29.53
-0.58
41.30
33.02
-21.78
12.05
530.00
1.38
5.95
-15.87
-7.23
-1.45
-15.53
16.59
1999.00
1.98
9.93
-7.04
8.11
2.53
28.75
72.54
1347.85
3.94
-1.07
-0.99
18.62
37.28
116.05
111.98
273.60
-0.73
0.96
-4.64
-6.84
-10.38
44.98
249.78
731.05
0.35
5.42
-25.10
-12.00
-7.32
90.98
316.79
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Lupin Ltd Risk Return Comparison

with peersNew

Lupin Ltd
Financial Comparison

with peers
Management Efficiency
Lupin Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
4.41
8.97
-99.01
47.57
Return on Assets (%)
2.36
5.58
-27.48
26.25
Return on capital Employed (%)
6.52
5.73
-130.86
23.02
Fixed Assets Turnover (x)
0.79
-1.83
-193.68
2.83
Profitability and Growth
Gross Profit Margin (%)
10.75
-8.24
-980.00
34.42
Operating Profit Margin(%)
17.24
0.75
-896.19
37.94
Net Profit margin (%)
3.62
1.93
-461.80
94.28
Financial Strength
Liquidity
Quick Ratio (x)
1.41
1.62
0.08
9.50
Current Ratio (x)
2.18
2.36
0.21
9.50
Cash ratio (x)
0.17
0.22
-0.52
1.40
Solvency
Debt Equity Ratio (x)
0.48
0.29
0.00
2.65
Coverage Ratios
Cash flows to long term debt (x)
4.04
3.92
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Lupin Ltd Share Holding as on 31-12-2019

CategoryNo. of sharesPercentage
Promoters211,279,64846.65
ForeignInstitutions111,708,66524.66
CentralGovt1,270,9430.28
Others13,030,8162.88
NBanksMutualFunds37,174,4238.21
GeneralPublic49,471,22910.92
FinancialInstitutions27,684,6366.11
ForeignPromoter1,286,3940.28

MF Ownership Of Lupin Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
HDFC Equity Direct-G
Portfolio as on 29-02-2020
Equity: Multi Cap
4094067
0.00%
1.22%
262.02
Franklin India Focused Equity Direct-G
Portfolio as on 29-02-2020
Equity: Multi Cap
3660253
100.00%
2.83%
234.26
Kotak Standard Multicap Direct-G
Portfolio as on 29-02-2020
Equity: Multi Cap
3000000
0.00%
0.65%
192.00
Franklin India Bluechip Direct-G
Portfolio as on 29-02-2020
Equity: Large Cap
2460252
64.02%
2.7%
157.46
L&T Tax Adv Direct-G
Portfolio as on 29-02-2020
Equity: ELSS
571600
0.00%
1.14%
36.58

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Lupin Ltd.

Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 25372.42 Crore) operating in Pharmaceuticals sector.

Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 10657.32 Crore to Sales Value (93.84 % of Total Sales), Export Incentives which contributed Rs 250.66 Crore to Sales Value (2.20 % of Total Sales) and Other Operating Revenue which contributed Rs 74.10 Crore to Sales Value (0.65 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 3716.09 Crore, down -13.52 % from last quarter Sales of Rs 4296.90 Crore and down -15.12 % from last year same quarter Sales of Rs 4377.94 Crore Company has reported net profit after tax of Rs -841.36 Crore in latest quarter.

The company’s top management includes Dr.K U Mada, Ms.Christine Mundkur, Mrs.Manju D Gupta, Mr.Richard Zahn, Mr.R A Shah, Mr.Nilesh Deshbandhu Gupta, Mr.Jean-Luc Belingard, Mr.Dileep C Choksi, Dr.Kamal K Sharma, Ms.Vinita Gupta. Company has B S R & Co. LLP as its auditors As on 31-12-2019, the company has a total of 452,906,754 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors